Longboard Pharmaceuticals Initiates Phase 3 Deep Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (Dees)
龍板製藥啓動第3期深海研究,評估Bexicaserin在發育性癲癇性腦病(DEE)中的作用
Longboard Pharmaceuticals Initiates Phase 3 Deep Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (Dees)
龍板製藥啓動第3期深海研究,評估Bexicaserin在發育性癲癇性腦病(DEE)中的作用
譯文內容由第三人軟體翻譯。